Akka Venture logo

Akka Venture

Europe, Ile-de-France, France, Paris

Description

Akka Venture is a Paris-based growth advisory firm that provides strategic and financial services to European companies.

Investor Profile

Akka Venture has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • France (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Clinical Trials
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Akka Venture frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 2
Ardian
Europe, Ile-de-France, France, Paris
Co-Investments: 2
NS
North America, California, United States, Palo Alto
Co-Investments: 1
Novo Nordisk
Europe, Hovedstaden, Denmark, Bagsværd
Co-Investments: 1
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Ace Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 1
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by Akka Venture?

Innate Pharma

Marseille, Provence-Alpes-Cote d'Azur, France

Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.

BiopharmaBiotechnologyClinical TrialsMedicalPharmaceutical
Series CSep 1, 2004
Amount Raised: $18,271,671
Innate Pharma

Marseille, Provence-Alpes-Cote d'Azur, France

Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.

BiopharmaBiotechnologyClinical TrialsMedicalPharmaceutical
Series BJan 1, 2002
Amount Raised: $17,766,486